Prev：Chemotaxis-guided nanoplatform for non-alcoholic steatohepatitis therapy via macrophage reprogramming, hepatoprotection and gut microbiome modulation(BMC1030-12.9)
Next：Chengcheng Wang¹ and Zheng He(KTA0002-)
